JP2008531693A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008531693A5 JP2008531693A5 JP2007558091A JP2007558091A JP2008531693A5 JP 2008531693 A5 JP2008531693 A5 JP 2008531693A5 JP 2007558091 A JP2007558091 A JP 2007558091A JP 2007558091 A JP2007558091 A JP 2007558091A JP 2008531693 A5 JP2008531693 A5 JP 2008531693A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- nsaid
- amount
- solvent
- dermatologically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 41
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 30
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 25
- 239000002904 solvent Substances 0.000 claims 22
- 239000002562 thickening agent Substances 0.000 claims 18
- 239000000651 prodrug Substances 0.000 claims 13
- 229940002612 prodrug Drugs 0.000 claims 13
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 claims 10
- 239000003410 keratolytic agent Substances 0.000 claims 7
- -1 UV blockers Substances 0.000 claims 5
- 125000002843 carboxylic acid group Chemical group 0.000 claims 5
- 229960003424 phenylacetic acid Drugs 0.000 claims 5
- 239000003279 phenylacetic acid Substances 0.000 claims 5
- 150000002148 esters Chemical class 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 239000003974 emollient agent Substances 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 2
- 229940124091 Keratolytic Drugs 0.000 claims 2
- 239000004909 Moisturizer Substances 0.000 claims 2
- 229920002125 Sokalan® Polymers 0.000 claims 2
- 239000005456 alcohol based solvent Substances 0.000 claims 2
- 125000000747 amidyl group Chemical group [H][N-]* 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 239000003086 colorant Substances 0.000 claims 2
- 239000006184 cosolvent Substances 0.000 claims 2
- 229960001680 ibuprofen Drugs 0.000 claims 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 2
- 230000001530 keratinolytic effect Effects 0.000 claims 2
- 239000000787 lecithin Substances 0.000 claims 2
- 229940067606 lecithin Drugs 0.000 claims 2
- 235000010445 lecithin Nutrition 0.000 claims 2
- 230000001333 moisturizer Effects 0.000 claims 2
- 239000003921 oil Substances 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- 239000002304 perfume Substances 0.000 claims 2
- 239000004584 polyacrylic acid Substances 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- XILVEPYQJIOVNB-UHFFFAOYSA-N 2-[3-(trifluoromethyl)anilino]benzoic acid 2-(2-hydroxyethoxy)ethyl ester Chemical compound OCCOCCOC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 XILVEPYQJIOVNB-UHFFFAOYSA-N 0.000 claims 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims 1
- TVQZAMVBTVNYLA-UHFFFAOYSA-N Pranoprofen Chemical compound C1=CC=C2CC3=CC(C(C(O)=O)C)=CC=C3OC2=N1 TVQZAMVBTVNYLA-UHFFFAOYSA-N 0.000 claims 1
- 230000003113 alkalizing effect Effects 0.000 claims 1
- 125000005907 alkyl ester group Chemical group 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 claims 1
- 229960000962 bufexamac Drugs 0.000 claims 1
- MXJWRABVEGLYDG-UHFFFAOYSA-N bufexamac Chemical compound CCCCOC1=CC=C(CC(=O)NO)C=C1 MXJWRABVEGLYDG-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 238000009792 diffusion process Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000032050 esterification Effects 0.000 claims 1
- 238000005886 esterification reaction Methods 0.000 claims 1
- 229960001493 etofenamate Drugs 0.000 claims 1
- 229960000192 felbinac Drugs 0.000 claims 1
- 239000010408 film Substances 0.000 claims 1
- 229960002390 flurbiprofen Drugs 0.000 claims 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 229960000905 indomethacin Drugs 0.000 claims 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims 1
- 229960000991 ketoprofen Drugs 0.000 claims 1
- 229960004752 ketorolac Drugs 0.000 claims 1
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000004530 micro-emulsion Substances 0.000 claims 1
- 229960002009 naproxen Drugs 0.000 claims 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 229960000649 oxyphenbutazone Drugs 0.000 claims 1
- HFHZKZSRXITVMK-UHFFFAOYSA-N oxyphenbutazone Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 HFHZKZSRXITVMK-UHFFFAOYSA-N 0.000 claims 1
- 229960001503 piketoprofen Drugs 0.000 claims 1
- ASFKKFRSMGBFRO-UHFFFAOYSA-N piketoprofen Chemical group C=1C=CC(C(=O)C=2C=CC=CC=2)=CC=1C(C)C(=O)NC1=CC(C)=CC=N1 ASFKKFRSMGBFRO-UHFFFAOYSA-N 0.000 claims 1
- 229960002702 piroxicam Drugs 0.000 claims 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 229960003101 pranoprofen Drugs 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 150000003873 salicylate salts Chemical class 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65808405P | 2005-03-03 | 2005-03-03 | |
| US68110205P | 2005-05-13 | 2005-05-13 | |
| US69020105P | 2005-06-14 | 2005-06-14 | |
| US11/361,384 US20070053984A1 (en) | 2005-03-03 | 2006-02-24 | Topical gels compositions |
| PCT/US2006/006780 WO2006096360A1 (en) | 2005-03-03 | 2006-02-27 | Topical gels compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008531693A JP2008531693A (ja) | 2008-08-14 |
| JP2008531693A5 true JP2008531693A5 (enExample) | 2009-04-09 |
Family
ID=42334238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007558091A Pending JP2008531693A (ja) | 2005-03-03 | 2006-02-27 | 局所用ゲル組成物 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1858503B1 (enExample) |
| JP (1) | JP2008531693A (enExample) |
| KR (1) | KR20080008321A (enExample) |
| AU (1) | AU2006220964A1 (enExample) |
| BR (1) | BRPI0608077A2 (enExample) |
| CA (1) | CA2599968A1 (enExample) |
| ES (1) | ES2437201T3 (enExample) |
| IL (1) | IL185531A0 (enExample) |
| MX (1) | MX2007010681A (enExample) |
| WO (1) | WO2006096360A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7914814B2 (en) | 1997-09-17 | 2011-03-29 | Strategic Science & Technologies, Llc | Topical delivery of arginine of cause beneficial effects |
| JP2007532697A (ja) | 2004-04-19 | 2007-11-15 | ストラテジック サイエンス アンド テクノロジーズ， エルエルシー | 局所的血流増大の有益な効果 |
| US9226909B2 (en) | 2004-04-19 | 2016-01-05 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
| US20080317684A1 (en) * | 2006-09-06 | 2008-12-25 | Isw Group, Inc. | Topical Compositions |
| CA2666398C (en) * | 2006-10-17 | 2015-08-18 | Ed Kisak | Diclofenac gel |
| ES2316312B1 (es) * | 2008-06-20 | 2010-02-08 | Ignacio Umbert Millet | Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas. |
| US8618164B2 (en) | 2009-03-31 | 2013-12-31 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
| US8546450B1 (en) | 2009-03-31 | 2013-10-01 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
| CN102481275B (zh) * | 2009-06-24 | 2014-07-23 | 战略科学技术有限公司 | 含有布洛芬的表面组合物 |
| US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
| AU2015203547B2 (en) * | 2009-06-24 | 2017-05-18 | Strategic Science & Technologies, Llc | Topical composition containing ibuprofen |
| EP2445493A1 (en) | 2009-06-24 | 2012-05-02 | Strategic Science & Technologies, LLC | Topical composition containing naproxen |
| US12138268B2 (en) | 2009-06-24 | 2024-11-12 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
| JP2011106846A (ja) * | 2009-11-13 | 2011-06-02 | Hamamatsu Univ School Of Medicine | 新規ｎｓａｉｄ潰瘍リスク判定方法 |
| KR101141938B1 (ko) * | 2010-01-22 | 2012-05-04 | 성균관대학교산학협력단 | 신규한 항생제 조성물 및 그람양성균의 치료 방법 |
| CN103442723A (zh) | 2010-12-29 | 2013-12-11 | 战略科学与技术有限责任公司 | 治疗变态反应和其它适应症的系统和方法 |
| EP2658551B1 (en) | 2010-12-29 | 2020-07-01 | Strategic Science & Technologies, LLC | Treatment of erectile dysfunction and other indications |
| PT2704703T (pt) | 2011-05-03 | 2019-10-25 | Aponia Laboratories Inc | Composições transdermais de ibuprofeno e seus métodos de utilização. |
| AU2015223035A1 (en) | 2014-02-26 | 2016-09-22 | Luma Therapeutics, Inc. | Ultraviolet phototherapy apparatuses and methods |
| US20190168016A1 (en) | 2016-02-09 | 2019-06-06 | Luma Therapeutics, Inc. | Methods, compositions and apparatuses for treating psoriasis by phototherapy |
| EP3651753A4 (en) * | 2017-07-11 | 2021-05-05 | University Of Miami | TOPICAL ACETAMINOPHEN FORMULATIONS FOR RELIEF ITCHING |
| EP4210714A4 (en) * | 2020-05-19 | 2025-01-29 | Mig Usa, Llc | TOPICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS596287B2 (ja) * | 1980-11-28 | 1984-02-10 | 日東電工株式会社 | 医薬製剤 |
| WO1987002891A1 (en) | 1985-11-07 | 1987-05-21 | Pfizer Inc. | Compounds and method for the topical treatment of inflammation and pain |
| US5093133A (en) * | 1990-01-24 | 1992-03-03 | Mcneil-Ppc, Inc. | Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
| US5639738A (en) | 1992-02-20 | 1997-06-17 | Hyal Pharmaceutical Corporation | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
| US5976566A (en) | 1997-08-29 | 1999-11-02 | Macrochem Corporation | Non-steroidal antiinflammtory drug formulations for topical application to the skin |
-
2006
- 2006-02-27 KR KR1020077022557A patent/KR20080008321A/ko not_active Withdrawn
- 2006-02-27 MX MX2007010681A patent/MX2007010681A/es not_active Application Discontinuation
- 2006-02-27 CA CA002599968A patent/CA2599968A1/en not_active Abandoned
- 2006-02-27 ES ES06736159.2T patent/ES2437201T3/es not_active Expired - Lifetime
- 2006-02-27 JP JP2007558091A patent/JP2008531693A/ja active Pending
- 2006-02-27 EP EP06736159.2A patent/EP1858503B1/en not_active Expired - Lifetime
- 2006-02-27 AU AU2006220964A patent/AU2006220964A1/en not_active Abandoned
- 2006-02-27 WO PCT/US2006/006780 patent/WO2006096360A1/en not_active Ceased
- 2006-02-27 BR BRPI0608077-4A patent/BRPI0608077A2/pt not_active IP Right Cessation
-
2007
- 2007-08-27 IL IL185531A patent/IL185531A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6271527B2 (ja) | レチノイドを含有する油／水エマルション型局所的組成物 | |
| JP2016500095A5 (enExample) | ||
| EP2125117A2 (fr) | Emulsion comprenant au moins un retinoide et du péroxyde de benzoyle | |
| WO2003028692A2 (fr) | Traitement de l'acne a l'aide d'acide oleanolique | |
| EP2097077A1 (fr) | Compositions comprenant du peroxyde de benzoyle, au moins un derive de l'acide naphtoïque et au moins un compose de type polymeres de polyurethane ou des derives de celui-ci, et leurs utilisations | |
| CN101553213A (zh) | 外用药物组合物及贴剂 | |
| CA2706655A1 (fr) | Compositions comprenant au moins un derive de l'acide naphtoique, du peroxyde de benzoyle et au moins un agent filmogene, leurs procedes de preparation, et leurs ulitisations | |
| CN104507470B (zh) | 含有类维生素a的o/w乳液类型的局部药物组合物 | |
| EP2854775A1 (fr) | Microcapsules contenant des rétinoïdes, leur procédé de préparation et compositions pharmaceutiques les contenant | |
| EP2787961A2 (fr) | Nouvelles émulsions huile-dans-eau riches en sels, stabilisées avec des gommes naturelles, à viscosité élevée et stables au cours du temps | |
| WO2012085480A1 (fr) | Mousses dermatologiques obtenues à partir d'un gel ou d'une suspension contenant une combinaison d'adapalène et de peroxyde de benzoyle | |
| CA2718755C (en) | Ketoprofen lysine salt-containing aqueous patch | |
| CA2710745A1 (fr) | Composition comprenant un retinoide et du peroxyde de benzoyle disperse | |
| JP2011510945A5 (enExample) | ||
| JP2026063380A5 (enExample) | ||
| Yuan et al. | A carrier-free therapeutic eutectogel: construction, physical properties, and anti-bacterial ability | |
| ZA200707357B (en) | Detection of very virulent infectious bursal disease virus | |
| CA2723313A1 (fr) | Compositions depigmentantes anhydres comprenant, au sein de la phase grasse un derive phenolique solubilise et un retinoide | |
| JP2004123575A (ja) | 外用ゲル状組成物 | |
| NO20055601L (no) | Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer | |
| FR2890861A1 (fr) | Compositions comprenant au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethanes ou des derives de celui-ci, leurs procede de preparation, et leur utilisation | |
| US11452701B2 (en) | Topical emulsion composition containing nonsteroidal anti-inflammatory drug | |
| KR100552651B1 (ko) | 비스테로이드성 소염진통제 함유 플라스터 | |
| TW201244760A (en) | Film-type external agent composition | |
| JP2009519303A (ja) | 少なくとも１種のレチノイド化合物と、少なくとも１種の抗刺激剤化合物とを含む組成物およびその使用 |